Comparing the Garmin Venu 3 / Garmin Venu 4 for Non-Invasive Vital Sign Monitoring to a Hospital-Grade Monitor

Recruiting now · Not applicable

Conditions studied: Validation of Vital Signs Measured by a Consumer-grade Smartwatch

In brief

This clinical trial evaluates the accuracy of the Garmin Venu 3 / Garmin Venu 4 smartwatch in measuring vital signs (heart rate, respiratory rate, SpO₂) compared to the clinically validated Philips IntelliVue X2. The study aims to determine whether the consumer-grade smartwatch can provide reliable data for remote patient monitoring, early hospital discharge, and chronic disease management, offering a more accessible and affordable alternative to MDR-certified devices.

Key facts

Study ID

NCT07360678

Run by

Ziekenhuis Oost-Limburg

People needed

30

Starts

2025-10-12

Expected to finish

2026-06-01

Last updated by the study team

2026-02-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provide signed and dated informed consent
• Adults older than 18 years of age
• Speak and understand the Dutch language
• Hospitalized for at least another 24 hours

You may not qualify if…

• Life expectancy is less than 30 days
• Patient is isolated due to infection control

Where it is running

• Ziekenhuis Oost-Limburg — Genk, Belgium (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.